New drug combo tested for tough cancers
NCT ID NCT05407675
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 29 times
Summary
This study tested a new drug called BMS-986408, given alone or with other cancer drugs (nivolumab and ipilimumab), in 68 people with advanced solid tumors that had not responded to other treatments. The main goal was to check safety and find the best dose. This is an early-stage trial, so it focuses on side effects and dosing, not on curing the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Hackensack, New Jersey, 07601, United States
-
Local Institution - 0003
Houston, Texas, 77030, United States
-
Local Institution - 0005
Ottawa, Ontario, K1H 8L6, Canada
-
Local Institution - 0006
Toronto, Ontario, M5G 2M9, Canada
-
Local Institution - 0007
Edmonton, Alberta, T6G 1Z2, Canada
-
Local Institution - 0010
Boston, Massachusetts, 02215, United States
-
Local Institution - 0011
Hamilton, Ontario, L8V5C2, Canada
-
Local Institution - 0012
Basel, 4031, Switzerland
-
Local Institution - 0014
Villejuif, Paris, 94800, France
-
Local Institution - 0015
Bordeaux, Aquitaine, 33076, France
-
Local Institution - 0018
Marseille, 13385, France
-
Local Institution - 0019
Toulouse, 31059, France
-
Local Institution - 0020
Geneva, 1205, Switzerland
-
Local Institution - 0021
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
-
Local Institution - 0022
Madrid, 28040, Spain
-
Local Institution - 0023
Madrid, 28050, Spain
-
Local Institution - 0024
Málaga, Andalusia, 29010, Spain
-
Local Institution - 0025
Madrid, Madrid, Comunidad de, 28009, Spain
Conditions
Explore the condition pages connected to this study.